MCID: CHL039
MIFTS: 34

Choledocholithiasis malady

Category: Gastrointestinal diseases

Aliases & Classifications for Choledocholithiasis

About this section

Aliases & Descriptions for Choledocholithiasis:

Name: Choledocholithiasis 11 49 38 13 67

Classifications:



External Ids:

Disease Ontology11 DOID:11755
MeSH38 D042883

Summaries for Choledocholithiasis

About this section
MalaCards based summary: Choledocholithiasis is related to ascending cholangitis and biliary dyskinesia. An important gene associated with Choledocholithiasis is GPT (Glutamic--Pyruvic Transaminase), and among its related pathways are FOXA2 and FOXA3 transcription factor networks and Lysosome. Affiliated tissues include liver, testes and heart.

Related Diseases for Choledocholithiasis

About this section

Diseases related to Choledocholithiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 100)
idRelated DiseaseScoreTop Affiliating Genes
1ascending cholangitis29.7ABCB4, ALB
2biliary dyskinesia29.2CTSC, SOBP
3extrahepatic cholestasis28.8ALB, ALPP, F2, GPT
4hepatocellular carcinoma28.5ABCB4, ALB, F2, GPT
5oral erosive lichen10.5GPT, SLC17A5
6patent foramen ovale10.5ABCB4, GPT
7nondystrophic myotonia10.5GPT, SLC17A5
8cat-scratch disease10.4GPT, SLC17A5
9paraneoplastic pemphigus10.4F2, GPT
10urinary bladder posterior wall cancer10.4ALB, GPT
11pontocerebellar hypoplasia10.3ABCB4, UGT1A1
12hypohidrosis10.3ABCB4, CTSC
13wernicke encephalopathy10.3ALB, UGT1A1
14cholelithiasis10.3
15fraxf syndrome10.3ALPP, GPT
16hereditary antithrombin deficiency type i10.3ALB, F2
17haim-munk syndrome10.2CTSC, SLC17A5
18marek disease10.2ALB, F2
19oral cavity carcinoma in situ10.2ALB, F2
20acute kidney tubular necrosis10.2ALB, F2
21parathyroid gland disease10.2ALB, F2
22cholangitis10.2
23splenic infarction10.2ALB, F2
24degenerative myopia10.2ALB, F2
25pericholangitis10.2ALB, F2
26anterior foramen magnum meningioma10.2ALB, F2
27spastic paraplegia 3a10.2F2, UGT1A1
28acute liver failure10.2ALB, F2
29dermatitis10.2ALB, F2
30ovarian cystic teratoma10.2ALB, F2
31lip carcinoma in situ10.2ALB, F2
32ischemic heart disease10.1ALB, F2
33alopecia10.1ALB, F2
34cutaneous porphyria10.1ALB, F2
35neurogenic bowel10.1ALB, F2
36amelogenesis imperfecta10.1ALB, F2
37pancreatitis10.1
38dentinogenesis imperfecta10.1ALB, F2
39acute lymphocytic leukemia10.1F2, GPT, SLC17A5
40bubonic plague10.1ALB, F2
41dermatomyositis10.1ABCB4, ALB, UGT1A1
42cholecystolithiasis10.1
43bartter disease10.0ALB, F2
44cholecystitis10.0
45ulcerative blepharitis10.0ALB, F2
46acute cholangitis10.0
47fibrous histiocytoma10.0ALB, F2, GPT
48angina pectoris10.0ALB, F2
49eczematous dermatitis of eyelid10.0ALB, F2, GPT
50spinocerebellar ataxia 810.0ALB, F2, GPT

Graphical network of the top 20 diseases related to Choledocholithiasis:



Diseases related to choledocholithiasis

Symptoms for Choledocholithiasis

About this section

Drugs & Therapeutics for Choledocholithiasis

About this section

Drugs for Choledocholithiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 41)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
MeperidineapprovedPhase 47157-42-14058
Synonyms:
1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester
1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]
1-Methyl-4-phenylisonipecotic acid, ethyl ester
1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester
4-Carbethoxy-1-methyl-4-phenylpiperidine
4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester
50-13-5 (hydrochloride)
57-42-1
610593_ALDRICH
610593_FLUKA
AC1L1HBJ
C07128
CHEBI:122528
CHEMBL607
CID4058
D008614
D08343
DB00454
DEA No. 9230
Demarol
Demerol
DivK1c_000983
Dolcontral
Dolosal
Dolsin
EINECS 200-329-1
Ethyl 1-methyl-4-phenylisonipecotate
Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate
HSDB 3116
IDI1_000983
Isonipecain
Isonipecaine
Isonipecaïne
Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester
KBio1_000983
 
L000908
LS-85121
Lidol
Lydol
Meperidine
Meperidine solution
Meperidol
Methyl phenylpiperidine carbonic acid ethyl ester
MolPort-001-785-564
N-Methyl-4-phenyl-4-carbethoxypiperidine
NINDS_000983
Nemerol
Operidine EPJ I
Operidine EPJ-I
Pethanol
Pethidin
Pethidine
Pethidine (INN)
Pethidine DBL
Pethidine DBL (TN)
Pethidine dbl
Pethidineter
Pethidinum
Pethidinum [INN-Latin]
Petidina
Petidina [INN-Spanish]
Petydyna
Petydyna [Polish]
Phetidine
Piperosal
Pipersal
Péthidine
Sauteralgyl
Spasmedal
Spasmodolin
UNII-9E338QE28F
YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)
meperidine
2
EtomidateapprovedPhase 46333125-97-236339, 667484
Synonyms:
(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate
(+)-Etomidate
(+)-ethyl 1-(α-methylbenzyl)imidazole-5-carboxylate
(+)-etomidate
(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester
(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
(d)-Etomidate
1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester
1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester
1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester
15301-65-2
1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester
3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester
33125-97-2
AC-5898
AC1L1VLF
AC1Q34BV
AC1Q64LP
AKOS000548952
Absele
Amidate
Amidate (TN)
Amidate (pharmaceutical)
Amidate, Etomidate
BAS 01947657
BRN 0665833
C07522
C14H16N2O2
CHEBI:129025
CHEMBL23731
CID36339
CPD000010931
D-Etomidate
D005045
D00548
 
DB00292
EINECS 251-385-9
Ethnor
Ethomidate
Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
Etomidate
Etomidate (USAN/INN)
Etomidate [USAN:BAN:INN]
Etomidato
Etomidato [INN-Spanish]
Etomidatum
Etomidatum [INN-Latin]
Etomidic acid
HMS1571A04
HMS1612G10
HMS2093P17
Hypnomidate
LS-78232
MLS000034952
MLS001240191
MolPort-000-917-569
Prestwick0_001041
Prestwick1_001041
Prestwick2_001041
R 16659
R 26490
R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate
R-26490
R26490
Radenarcon
Radenarkon
S1329_Selleck
SAM002548930
SBB066197
SMR000010931
SPBio_002901
UNII-Z22628B598
ethyl 3-(1-phenylethyl)imidazole-4-carboxylate
3
Midazolamapproved, illicitPhase 468459467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
 
Dormicum
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
4
Ursodeoxycholic acidapproved, investigationalPhase 495128-13-231401
Synonyms:
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oate
(3a,5b,7b)-3,7-dihydroxy-cholan-24-oic acid
(3a,5b,7b)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid
(3alpha,5beta,7beta,8xi)-3,7-dihydroxycholan-24-oic acid
(3α,5β,7β)-3,7-dihydroxycholan-24-oic acid
(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid
128-13-2
17-beta-(1-Methyl-3-carboxypropyl)etiocholane-3-alpha,7-beta-diol
3 alpha,7 beta-Dihydroxy-5 beta-cholan-24-oic Acid
3,7-Dihydroxycholan-24-oic acid
3-alpha,7-beta-Dihydroxy-5-beta-cholanoic acid
3-alpha,7-beta-Dihydroxycholanic acid
3-alpha,7-beta-Dioxycholanic acid
3a,7b-Dihydroxy-5b-cholan-24-oate
3a,7b-Dihydroxy-5b-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid
3alpha,7beta-Dihydroxy-5beta-cholanic acid
4-10-00-01604 (Beilstein Handbook Reference)
50809-41-1
5beta-Cholan-24-oic acid-3alpha,7beta-diol
5beta-Cholanic Acid-3alpha,7beta-diol
7-beta-Hydroxylithocholic acid
7beta-Hydroxylithocholic acid
80225-86-1
AB00513977
AC-18919
AC-2081
AC1L1LJH
Acide ursodesoxycholique
Acide ursodesoxycholique [INN-French]
Acido ursodeossicolico
Acido ursodeossicolico [Italian]
Acido ursodeoxicolico
Acido ursodeoxicolico [INN-Spanish]
Acidum ursodeoxycholicum
Acidum ursodeoxycholicum [INN-Latin]
Actigall
Actigall (TN)
Antigall
Arsacol
BB_NC-2372
BPBio1_001052
BRN 3219888
BSPBio_000956
C07880
C24H40O4
CCRIS 5502
CHEBI:9907
CHEMBL1551
CHEMBL73390
CID11516715
CID31401
CPD-10534
CPD000058403
Cholan-24-oic acid, 3,7-dihydroxy-, (3-alpha,5-beta,7-beta)- (9CI)
Cholit-ursan
D00734
DB01586
Delursan
Deoxyursocholic Acid
Destolit
Deursil
Dom-ursodiol c
EINECS 204-879-3
HMS1570P18
 
ISO-URSODEOXYCHOLIC ACID
IU5
LMST04010033
LS-53033
Litursol
Lyeton
MLS000028461
MLS001066373
MolPort-001-794-630
MolPort-005-932-884
NCGC00179363-01
NCI60_028904
NSC 657950
NSC 683769
PHL-ursodiol c
PMS-ursodiol c
Peptarom
Prestwick0_000958
Prestwick1_000958
Prestwick2_000958
Prestwick3_000958
S1643_Selleck
SAM002264653
SMP2_000012
SMR000058403
SPBio_003105
Sodium Ursodeoxycholate
Solutrat
U-9000
U0030
U5127_SIGMA
UDCA
UDCS
UNII-724L30Y2QR
URSODEOXYCHOLIC ACID
UrSO
Urosdesoxycholate
Urosdesoxycholic acid
Urosiol
Ursacholic Acid
Ursacol
Urso
Urso (TN)
Urso 250
Urso DS
Urso Forte
Ursobilin
Ursochol
Ursodamor
Ursodeoxy cholic acid
Ursodeoxycholate
Ursodeoxycholic acid
Ursodeoxycholic acid (JP15/INN)
Ursodeoxycholic acid, UDCA, Ursosan, Ursofalk, Urso Forte, Udiliv, Ursodiol
Ursodeoxycholicacid
Ursodesoxycholic acid
Ursodexycholate
Ursodexycholic Acid
Ursodexycholic acid
Ursodiol
Ursodiol (USP)
Ursodiol [USAN]
Ursofalk
Ursolvan
Ursosan
chenodeoxycholic acid
ursodeoxycholate
ursodiol
5Neurotransmitter AgentsPhase 417734
6NarcoticsPhase 43486
7Psychotropic DrugsPhase 46279
8Adjuvants, AnesthesiaPhase 41588
9Cholagogues and CholereticsPhase 4127
10Tranquilizing AgentsPhase 44164
11Peripheral Nervous System AgentsPhase 422776
12Gastrointestinal AgentsPhase 48109
13Anesthetics, GeneralPhase 42787
14AnestheticsPhase 49001
15Analgesics, OpioidPhase 43091
16Hypnotics and SedativesPhase 42485
17Anesthetics, IntravenousPhase 42406
18AnalgesicsPhase 411287
19GABA ModulatorsPhase 4864
20GABA AgentsPhase 41622
21Central Nervous System DepressantsPhase 412806
22Anti-Anxiety AgentsPhase 41816
23
Chlorhexidineapproved, vet_approved47255-56-19552079, 2713
Synonyms:
1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]
1,1'-Hexamethylene bis(5-(P-chlorophenyl)biguanide)
1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)
1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide
1,6-Bis(5-(p-chlorophenyl)biguandino)hexane
1,6-Bis(p-chlorophenyldiguanido)hexane
1,6-Di(4'-chlorophenyldiguanido)hexane
1,6-Di(N-p-chlorophenyldiguanido)hexane
24798_FLUKA
282227_ALDRICH
348031_ALDRICH
4-12-00-01201 (Beilstein Handbook Reference)
55-56-1
AB00053427
AB1003159
AVAGARD
BPBio1_000272
BRN 2826432
BSPBio_000246
BSPBio_001977
C06902
C22H30Cl2N10
CAS-55-56-1
CCRIS 9230
CHEBI:3614
CHEMBL790
CID9552079
Chlorhexidin
Chlorhexidin [Czech]
Chlorhexidine
Chlorhexidine (INN)
Chlorhexidine Base
Chlorhexidine [INN:BAN]
Chlorhexidine gluconate
Chlorhexidinum
Chlorhexidinum [INN-Latin]
Cloresidina
Cloresidina [DCIT]
Clorhexidina
Clorhexidina [INN-Spanish]
D07668
DB00878
Decanoylacetaldehyde Sodium Sulfide
Dentisept [veterinary]
Dentisept [veterinary] (TN)
DivK1c_000761
EINECS 200-238-7
Fimeil
HMS1568M08
HSDB 7196
Hexadol
Hibiclens
Hibispray
Hibistat
I06-0621
I14-0050
IDI1_000761
 
KBio1_000761
KBio2_000717
KBio2_003285
KBio2_005853
KBio3_001197
KBioGR_000774
KBioSS_000717
LS-43917
Lisium (*Dihydrochloride*)
MK-412A
MLS001332387
MLS001332388
MLS002154209
Merfen-incolore
Merfen-incolore (TN)
MolPort-002-541-741
N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide
N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide
NCGC00016246-01
NCGC00091025-01
NCGC00091025-02
NINDS_000761
NSC526936
Nolvasan
Nolvasan (*Diacetate*)
Novalsan
Oro-Clense
Peridex
Periogard
Prestwick0_000143
Prestwick1_000143
Prestwick2_000143
Prestwick3_000143
Prestwick_53
QTL1_000020
Rotersept
SMR000857146
SPBio_000210
SPBio_002185
STK089248
STOCK1S-18831
Savloclens
Savlon babycare
Sebidin A
Sodium Houttuyfonamide
Soretol
Spectrum2_000135
Spectrum3_000339
Spectrum4_000277
Spectrum5_001322
Spectrum_000237
Sterido
Sterilon
Superspray
Tubulicid
UNII-R4KO0DY52L
chlorhexidine
24
Cefotaximeapproved3663527-52-6456256, 5742673
Synonyms:
(6R,7R)-3-(Acetoxymethyl)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R)-3-Acetoxymethyl-7-{2-(2-amino-thiazol-4-yl)-2-[(Z)-methoxyimino]-acetylamino}-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7R,Z)-3-(Acetoxymethyl)-7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
60846-21-1
63527-52-6
63527-53-7
64485-93-4 (mono-hydrochloride salt)
AC-217
AC1L1E42
AC1L9UKL
AC1NSF5T
AC1NSF6T
AC1NUIF8
AC1NX3QV
AC1NZU9Q
AC1O712I
AC1O7G8N
AC1OC9NB
AKOS003286450
BIDD:GT0681
BPBio1_000240
BRD-K78364995-236-03-5
BRD-K99586414-236-02-3
BSPBio_000218
BSPBio_001961
C06885
C16H17N5O7S2
CE3
CHEBI:204928
CHEMBL102
CID2632
CID456256
CID5361298
CID5361354
CID5479527
CID5742673
CID5916965
CID6540461
CID6604086
CID6914272
CID7566336
CID9868614
Cefotaxim
Cefotaxim Hikma
Cefotaxim Hikma (TN)
Cefotaxima
Cefotaxima [INN-Spanish]
 
Cefotaxime (INN)
Cefotaxime [INN:BAN]
Cefotaxime acid
Cefotaxime sodium
Cefotaximum
Cefotaximum [INN-Latin]
Cephotaxim
Cephotaxime
Claforan
Claforan (*Sodium salt*)
Céfotaxime
D07647
DB00493
DivK1c_000767
EINECS 264-299-1
HMS2090M11
IDI1_000767
KBio1_000767
KBio2_000548
KBio2_003116
KBio2_005684
KBio3_001181
KBioGR_000736
KBioSS_000548
Klaforan
LS-149920
LS-187246
Lopac0_000278
MolPort-002-339-742
MolPort-005-934-578
MolPort-006-834-754
NCGC00021126-01
NINDS_000767
Prestwick0_000139
Prestwick1_000139
Prestwick2_000139
Prestwick3_000139
RU 24662
Ru-24756
SPBio_000138
SPBio_002157
STK383264
Spectrum2_000119
Spectrum3_000331
Spectrum4_000268
Spectrum5_000667
Spectrum_000108
UNII-N2GI8B1GK7
cefotaxime
25
Cefoxitinapproved3635607-66-0441199
Synonyms:
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-(carbamoyloxymethyl)-7-methoxy-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(Carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
(6R,7S)-3-[(carbamoyloxy)methyl]-7-methoxy-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
(6R,7S)-3-{[(aminocarbonyl)oxy]methyl}-7-(methyloxy)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(2-thienylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
3-[(carbamoyloxy)methyl]-7alpha-methoxy-7beta-[(thiophen-2-yl)acetamido]-3,4-didehydrocepham-4-carboxylic acid
33564-30-6
35607-66-0
AB00513931
AC-1303
AC1L9AQF
AC1L9SPP
BIDD:GT0505
BPBio1_000863
BSPBio_000783
BSPBio_003101
C06887
C08106
CEFOXITIN SODIUM
CFX
CHEBI:209807
CHEBI:53655
CHEMBL1200530
CHEMBL996
CID441199
CID441392
CPD-9233
CPD000058809
Cefoxitin
Cefoxitin (USAN/INN)
Cefoxitin sodium (JAN/USP)
Cefoxitin sodium salt
Cefoxitina
Cefoxitine
Cefoxitinum
Ceftoxitin
Cephoxitin
D00913
D02345
DB01331
 
DivK1c_000576
HMS1570H05
HMS1921F14
HMS2092P11
HMS501M18
IDI1_000576
KBio1_000576
KBio2_001879
KBio2_004447
KBio2_007015
KBio3_002601
KBioGR_000626
KBioSS_001879
MLS000028557
MLS001076334
MLS002222151
Mefoxin
Mefoxin (TN)
Mefoxitin
MolPort-003-666-398
NCGC00093351-02
NCGC00093351-03
NINDS_000576
Prestwick0_000832
Prestwick1_000832
Prestwick2_000832
Prestwick3_000832
Prestwick_12
Rephoxitin
SAM002564251
SMR000058809
SPBio_000771
SPBio_002704
SPECTRUM1502031
Spectrum 001399
Spectrum2_000676
Spectrum3_001491
Spectrum4_000153
Spectrum5_001145
Spectrum_001399
ZINC03830449
cefoxitin
26Plasminogen InactivatorsEarly Phase 110
27Tissue Plasminogen ActivatorEarly Phase 1231
28PlasminogenEarly Phase 1236
29Plasminogen Activator Inhibitor 1Early Phase 129
30Anti-Bacterial Agents10884
31Antibiotics, Antitubercular6972
32Disinfectants547
33glucagon462
34Chlorhexidine gluconate472
35Glucagon-Like Peptide 1694
36Anti-Infective Agents, Local1785
37Anti-Infective Agents21402
38Scopolamine hydrobromide67114-49-8
39Butylscopolammonium Bromide67
40Cephalosporins164
41Antitubercular Agents1272

Interventional clinical trials:

(show all 38)
idNameStatusNCT IDPhase
1Etomidate vs. Midazolam for Sedation During ERCPCompletedNCT02027311Phase 4
2UDCA for Symptomatic Gallstone DiseaseCompletedNCT00161083Phase 4
3Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the PapillaRecruitingNCT02703077Phase 4
4Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD StonesCompletedNCT02592811Phase 3
5Magnetic Resonance Cholangiopancreatography Versus Endoscopic Retrograde Cholangiopancreatography in the Approach to Patients With Suspected Biliary ObstructionTerminatedNCT01424657Phase 3
6Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/CholedocholithiasisUnknown statusNCT00416234
7A Prospective Randomized Study Comparing Different Dilation Durations for Endoscopic Papillary Balloon DilatationUnknown statusNCT00451581
8Comparison of Papillary Balloon Dilatation Vs.Sphincterotomy for Lithotripsy in Difficult Sphincterotomy or Distal CBD TaperingUnknown statusNCT00329888
9Prospective Study to Investigate the Frequency of Possible Bacterial Entry Into the Bloodstream (Bacteremia) and Infectious Complications Associated With the Use of the Spyglass Cholangioscopy System During ERCP (Endoscopic Retrograde CholangiopancreatogrUnknown statusNCT01414400
10Timing of Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiography for Acute Biliary PancreatitisUnknown statusNCT01687959Early Phase 1
11Randomized Trial of ERCP Then Laparoscopic Cholecystectomy vs. Laparoscopic Cholecystectomy Plus Laparoscopic Common Bile Duct Exploration in Patients With Likely CholedocholithiasisCompletedNCT00807729
12EUS Guided ERCP in Bile Duct Stone RemovalCompletedNCT02870686
13Left Lateral Position and Prone Position for Endoscopic Retrograde CholangiopancreatographyCompletedNCT02594475
14Effect of 8.5 F Plastic Stent Without Proximal Flap on Prevention of Post-ERCP CholangitisCompletedNCT02594891
15Study of Endoscopic Sphincterotomy With Needle Knife Papillotome in Patients of Ampullary Impacted StoneCompletedNCT00173368
16Laryngeal Mask Airway Supreme Versus the Tracheal Tube as an Airway Device in Elective Laparoscopic CholecystectomyCompletedNCT02037958
17Comparison Between Pre and Intraoperative ERCP in Treatment of Common Bile Duct StonesCompletedNCT01046552
18Prospective Study of the Risk of Bacteremia in Directed Cholangioscopic Examination of the CBDCompletedNCT01673269
19Prospective Multicenter Evaluation of a New Short-access-cholangioscope for Biliary Duct Strictures and Gall StonesCompletedNCT01683240
20Loop-tipped Guidewire in Selective Biliary CannulationCompletedNCT02028845
21Routine Bile Collection for Microbiological Analysis During CholangiographyCompletedNCT01003782
22Cytological Evaluation of Biliary Epithelium After Endoscopic SphincterotomyCompletedNCT01135732
23Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic CholecystectomyCompletedNCT01824186
24Incidence and Risk Factor of Post-ERCP Pancreatitis in Chronic PancreatitisCompletedNCT02781987
25Early EUS in Acute Biliary PancreatitisCompletedNCT02430285
26Comparison of LCBDE vs ERCP + LC for CholedocholithiasisRecruitingNCT02515474
27Laser Versus Mechanical Lithotripsy of Bile Duct StonesRecruitingNCT01759979
28Cholangiography Using Carbon Dioxide Versus Iodinated Contrast in ERCPRecruitingNCT02611453
29Optimization and Cost-effective Analysis of Secondary Biliary Stones' ManagementsRecruitingNCT02554097
30Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal DisordersRecruitingNCT01438385
31Los Angeles Prospective GI Biliary and EUS SeriesRecruitingNCT02196935
32Prospective Validation of "Cholecystectomy First" Strategy for Gallstone MigrationActive, not recruitingNCT02461147
33The Clinical Characteristics of the Patients With Choledocholithiasis Without CholangitisEnrolling by invitationNCT02647593
34Direct Peroral Cholangioscopy by Using an Ultra-slim Upper EndoscopeEnrolling by invitationNCT02276157
35Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction PatientNot yet recruitingNCT02958059
36Study Investigating the Best Method of Treatment of Bile Duct Stones in Higher Risk PatientsTerminatedNCT00612846
37Management of Common Bile Duct (CBD) Stones at Laparoscopic CholecystectomyTerminatedNCT00124033
38Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone ClearanceWithdrawnNCT01475864

Search NIH Clinical Center for Choledocholithiasis


Cochrane evidence based reviews: choledocholithiasis

Genetic Tests for Choledocholithiasis

About this section

Anatomical Context for Choledocholithiasis

About this section

MalaCards organs/tissues related to Choledocholithiasis:

35
Liver, Testes, Heart

Animal Models for Choledocholithiasis or affiliated genes

About this section

Publications for Choledocholithiasis

About this section

Articles related to Choledocholithiasis:

(show top 50)    (show all 606)
idTitleAuthorsYear
1
Endoscopic ultrasound versus magnetic resonance cholangiopancreatography in suspected choledocholithiasis: A systematic review. (27080611)
2016
2
Accuracy of scoring systems for suspected choledocholithiasis: A 5-variable score system versus ASGE clinical guidelines. (27089986)
2016
3
Nationwide Assessment of Trends in Choledocholithiasis Management in the United States From 1998 to 2013. (27556900)
2016
4
Accuracy of ASGE criteria for the prediction of choledocholithiasis. (27063334)
2016
5
Comparison Between Endoscopic Biliary Stenting and Nasobiliary Drainage in Patients with Acute Cholangitis due to Choledocholithiasis: Is Endoscopic Biliary Stenting Useful? (26897928)
2015
6
Detectability of choledocholithiasis on CT: The effect of positive intraduodenal enteric contrast on portovenous contrast-enhanced studies. (26458858)
2015
7
Learning curve and outcome of laparoscopic transcystic common bile duct exploration for choledocholithiasis. (26395452)
2015
8
Management of Suspected Choledocholithiasis: A Decision Analysis for Choosing the Optimal Imaging Modality. (26399621)
2015
9
'Single-Sitting' Laparoscopic Cholecystectomy and Endoscopic Removal of Common Bile Duct Stone for Cholelithiasis and Choledocholithiasis: a Feasibility Study. (26730094)
2015
10
Endoscopic Sphincterotomy Using the Rendezvous Technique for Choledocholithiasis during Laparoscopic Cholecystectomy: A Case Report. (25298761)
2014
11
Successful single-session endosonography-based endoscopic retrograde cholangiopancreatography without fluoroscopy in pregnant patients with suspected choledocholithiasis: a case series. (23798477)
2013
12
Endoscopic papillary balloon dilation for a 7-year-old girl with choledocholithiasis. (23679173)
2013
13
Risk factors of choledocholithiasis formation after liver transplantation. (23558078)
2013
14
Relationship of CA 19-9 with choledocholithiasis and cholangitis. (21796554)
2011
15
Endoscopic papillary balloon dilation for removal of choledocholithiasis: indications, advantages, complications, and long-term follow-up results. (21461066)
2011
16
Laparoscopic exploration of the common bile duct with a rigid scope in patients with problematic choledocholithiasis. (20354699)
2010
17
Selective use of magnetic resonance cholangiopancreatography in clinical practice may miss choledocholithiasis in gallstone pancreatitis. (21092433)
2010
18
Preoperative diagnosis of choledocholithiasis: the role of MRCP. (19516211)
2009
19
Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis. (19210291)
2009
20
Management of choledocholithiasis in patients undergoing cholecystectomy. (19566539)
2009
21
Patients with a high probability of choledocholithiasis are best managed with ERCP without EUS. (19327495)
2009
22
Laparoendoscopic "rendezvous" versus laparoscopic antegrade sphincterotomy for choledocholithiasis. (18707043)
2008
23
Balloon sphincteroplasty in the management of choledocholithiasis in a 10-week-old infant. (18287994)
2008
24
Common bile duct thrombi secondary to hepatoma, with biliary invasion mimicking a choledocholithiasis (with video). (17258996)
2007
25
Suspected choledocholithiasis: endoscopic ultrasound or magnetic resonance cholangio-pancreatography? A systematic review. (18049172)
2007
26
Laparoscopic management of difficult recurrent choledocholithiasis. (17651582)
2007
27
Optimizing choledocholithiasis management: a cost-effectiveness analysis. (17224499)
2007
28
Conversion rate for laparoscopic cholecystectomy after endoscopic retrograde cholangiography in the treatment of choledocholithiasis: does the time interval matter? (17031740)
2006
29
EUS vs MRCP for detection of choledocholithiasis. (16860077)
2006
30
Echo-endoscopy versus endoscopic retrograde cholangiography for the diagnosis of choledocholithiasis: the influence of the size of the stone and diameter of the common bile duct. (16444379)
2005
31
Accuracy of computed tomographic intravenous cholangiography (CT-IVC) with iotroxate in the detection of choledocholithiasis. (15627178)
2005
32
Role of endoscopic retrograde cholangiopancreatography in the management of suspected choledocholithiasis. (12618941)
2003
33
Cholelithiasis and choledocholithiasis after sequential cytarabine and asparaginase. (12902918)
2003
34
Endoscopic management of choledocholithiasis resulting from a biliary metal stent. (12822110)
2003
35
Treatment of choledocholithiasis in pregnancy: a case report. (12592428)
2003
36
Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. (12603536)
2003
37
Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis. (12811312)
2003
38
Recurrence of biliary symptoms after endoscopic sphincterectomy for choledocholithiasis in patients with gallbladder stones. (11911095)
2002
39
Choledocholithiasis in the Setting of Portal Hypertension. (11469971)
2001
40
Successful endoscopic sphincterotomy using a papillotome tipped with a balloon for cases of choledocholithiasis complicated by duodenal diverticula. (11721786)
2001
41
Long-term stenting for choledocholithiasis. (10946479)
2000
42
Management of choledocholithiasis during pregnancy by magnetic resonance cholangiography and laparoscopic common bile duct stone extraction. (11083218)
2000
43
Eight years' experience with the use of a transcystic common bile duct duodenal double-lumen catheter for the treatment of choledocholithiasis. (9780991)
1998
44
Assessment of indicators for predicting choledocholithiasis before laparoscopic cholecystectomy. (17344723)
1998
45
Laparo-endoscopic "rendezvous": a new technique in the choledocholithiasis treatment. (9840078)
1998
46
Choledocholithiasis and gallstone pancreatitis. (9512804)
1997
47
Biliary stents as temporary treatment for choledocholithiasis in pregnant patients. (9260726)
1997
48
Predicting the presence of choledocholithiasis in patients with symptomatic cholelithiasis. (8677945)
1996
49
Laparoscopic treatment of known choledocholithiasis. (8658332)
1996
50
Left lateral laparoscopic cholecystectomy and its relevance to choledocholithiasis. (8363482)
1993

Variations for Choledocholithiasis

About this section

Expression for genes affiliated with Choledocholithiasis

About this section
Search GEO for disease gene expression data for Choledocholithiasis.

Pathways for genes affiliated with Choledocholithiasis

About this section

Pathways related to Choledocholithiasis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5ALB, F2
29.3CTSC, GUSB, SLC17A5

GO Terms for genes affiliated with Choledocholithiasis

About this section

Cellular components related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lysosomeGO:00057649.0CTSC, GUSB, SLC17A5
2extracellular spaceGO:00056158.4ALB, CTSC, F2, GPT, GUSB

Biological processes related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1acute-phase responseGO:00069539.7F2, UGT1A1
2response to organic substanceGO:00100339.1ALB, CTSC, UGT1A1

Molecular functions related to Choledocholithiasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1pyridoxal phosphate bindingGO:00301709.7ALB, GPT

Sources for Choledocholithiasis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet